Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025
Tonmya was approved by FDA on August 15, 2025 for the treatment of fibromyalgia and is the first new FDA...
Clinical Trial
Ocular Therapeutix™ to Host Investor Day on September 30, 2025
Company to highlight ongoing AXPAXLI™ wet AMD registrational program, strategy and next steps in NPDR and DME, and global commercial...
Dianthus Therapeutics Announces Positive Data for Claseprubart (DNTH103) from the Phase 2 MaGic Trial in Generalized Myasthenia Gravis, Supporting Its Potential Best-In-Class Profile
Claseprubart 300mg and 600mg Q2W doses both achieved statistically significant and clinically meaningful improvements in Myasthenia Gravis Activities of Daily...
Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies
In separate cat and birch allergen-challenge trials, single doses of allergen-specific antibody blockers significantly reduced allergy symptoms compared to placebo...
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
HUNTSVILLE, AL, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing...
Rapport Announces Positive Topline Results from Phase 2a Clinical Trial of RAP-219 in Patients with Focal Onset Seizures
Trial met primary long episode endpoints with high statistical significance, and RAP-219 was generally well toleratedPatients achieved 77.8% reduction in...
DEA National Marijuana Embarrassment: DEA Forces VA to Import Cannabis After Blocking MMJ BioPharma Cultivation US Supply
Is the DEA the Epitome of Ineptitude?"Why is the VA importing cannabis that U.S. companies have been ready to produce...
Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific
Hemogenyx Pharmaceuticals Announces Manufacturing Partnership with Made Scientific to Advance HG-CT-1 CAR-T Therapy CITY OF LONDON, GB / ACCESS Newswire...
Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism
- 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5...
The Global PAD Association has presented the 2025 Walking As Therapy Breakthrough Research of the Year award to The STRIDE Trial Research Team led by Dr. Marc P. Bonaca
AURORA, CO / ACCESS Newswire / September 5, 2025 / The Global PAD Association has presented the 2025 Walking As...
Over 275 Duchenne Patients Enrolled in Pre-Approval Treatment Programs Around the World with myTomorrows’ Platform
Ahead of World Duchenne Awareness Day, myTomorrows celebrates referring more than 600 Duchenne muscular dystrophy patients to clinical trials and...
Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board
VANCOUVER, BC / ACCESS Newswire / September 5, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased...
Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~...
Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn’s Disease (FSCD)
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Patient dosing expected to...
Trump’s DEA Must Choose: Reward Illegal Marijuana Operators or Sanction Science?
As the Trump administration cracks down on foreign drug cartels, MMJ BioPharma Cultivation exposes a hypocritical domestic policy: rewarding illegal...
Global Working Group Releases Publication on Responsible Use of Artificial Intelligence in Creating Lay Summaries of Clinical Trial Results
New publication underscores the importance of human oversight, transparency, and patient involvement in AI-assisted lay summaries. BOSTON, Sept. 4, 2025...
Global Working Group Releases Publication on Responsible Use of Artificial Intelligence in Creating Lay Summaries of Clinical Trial Results
New publication underscores the importance of human oversight, transparency, and patient involvement in AI-assisted lay summaries. BOSTON, Sept. 4, 2025...
New Study Boosts Trial Precision in Measuring Pain, Mood, and Fatigue
Published in the Journal of Pain, Cognivia's research brings more objectivity to pain trials, leading to cleaner data, smarter decisions,...
One2Treat raises capital to further accelerate software platform development and relocates offices to support rapid growth
LOUVAIN-LA-NEUVE, Belgium, Sept. 4, 2025 /PRNewswire/ -- One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical...
Xtalks Announces its Life Science Webinar Calendar for September 2025
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, biotech, cell and gene therapy, clinical trials, drug discovery &...